Cerus to Release Third Quarter 2011 Results on November 1, 2011

Show Health and Fitness Publications

Fri, October 21, 2011

[ Fri, Oct 21st 2011 ] - Market Wire

Reduzierte Schubhufigkeit und Behinderungsprogres .. durch oral verabreichtes BG-12 (Dimethylfumarat):

Thu, October 20, 2011

[ Thu, Oct 20th 2011 ] - Market Wire

Biogen Idec und Elan melden Verlngerung der PDUFA-Frist

[ Thu, Oct 20th 2011 ] - Market Wire

Critical Outcome Technologies Inc. Successfully Completes Critical Study

[ Thu, Oct 20th 2011 ] - Market Wire

Analyst View, Impact of Global Events - Research .. on &;; Johnson and Endo Pharmaceuticals

[ Thu, Oct 20th 2011 ] - Market Wire

Dendreon Announces Webcast Presentations at Upcoming Conferences

[ Thu, Oct 20th 2011 ] - Market Wire

Alnylam to Webcast Presentation at the Newsmakers in the Biotech Industry 2011 Conference

[ Thu, Oct 20th 2011 ] - Market Wire

Allon Therapeutics Announces Completion of Patient Enrollment in Pivotal Trial

[ Thu, Oct 20th 2011 ] - Market Wire

POZEN Announces November 3, 2011 Webcast of Third Quarter 2011 Results

[ Thu, Oct 20th 2011 ] - Market Wire

Geron Presents Clinical Data Update From GRNOPC1 Spinal Cord Injury Trial

[ Thu, Oct 20th 2011 ] - Market Wire

Cambridge Heart Announces Initial Results of OEM Module Marketing Promotion

[ Thu, Oct 20th 2011 ] - Market Wire

Manchester Heart Centre in United Kingdom Obtains VMS(TM) Heart Analysis System

[ Thu, Oct 20th 2011 ] - Market Wire

Covidien Releases Clinical Data from Largest Pros .. Plaque Excision for Treatment of Peripheral Arter

[ Thu, Oct 20th 2011 ] - Market Wire

Five Star Quality Care, Inc. Third Quarter Conference Call Scheduled for Thursday, October 27th

[ Thu, Oct 20th 2011 ] - Market Wire

Device Master File for OncoSec Medical System Completed and Submitted to FDA

[ Thu, Oct 20th 2011 ] - Market Wire

Comprehensive Care Corporation CEO Clark A. Marcus Praised for U.S. Chamber of Commerce Service

Wed, October 19, 2011

[ Wed, Oct 19th 2011 ] - Market Wire

Sun Healthcare Group, Inc. to Release Third-Quarter Results for 2011 and Schedules Conference Call

[ Wed, Oct 19th 2011 ] - Market Wire

Gegevens over vroeg gebruik en baten op lange ter .. d op 5de gezamenlijk driejaarlijks congres over b

[ Wed, Oct 19th 2011 ] - Market Wire

Des r©sultats relatifs l'utilisation pr©coce et .. YSABRI sont pr©sent©s l'occasion du 5e Congrs t

[ Wed, Oct 19th 2011 ] - Market Wire

Los datos sobre el uso temprano y los beneficios .. sido presentados en el 5 congreso trienal conjun

[ Wed, Oct 19th 2011 ] - Market Wire

Diligent Board Member Services Ranked Number 156 .. rth America on Deloitte's 2011 Technology Fast 50

[ Wed, Oct 19th 2011 ] - Market Wire

Marina Biotech Demonstrates In Vivo Dose-Dependen .. erability With a CRN-Substituted miRNA Antagonist

[ Wed, Oct 19th 2011 ] - Market Wire

UNITEDHEALTHCARE OFRECE AUDFONOS SIN COSTO DE DES .. PARA LOS BENEFICIARIOS DEL CONDADO DE MIAMI-DADE

[ Wed, Oct 19th 2011 ] - Market Wire

Vertex Submits Application for Priority Review an .. 770, ivacaftor) in the U.S. as First Potential Me

[ Wed, Oct 19th 2011 ] - Market Wire

Ligand Enters into Platform Captisol® License Agreement with SAGE Therapeutics

[ Wed, Oct 19th 2011 ] - Market Wire

Single Pharmaceutical-Based Strategy Aims to Solve Neurological and Psychiatric Disorders

[ Wed, Oct 19th 2011 ] - Market Wire

Daten ber Vorteile frhzeitiger bzw. langfristiger .. f 5. dreijhrlichem gemeinsamem Kongress von ECTRI

[ Wed, Oct 19th 2011 ] - Market Wire

Astex Pharmaceuticals to Present at BIO Investor Forum on October 26th

[ Wed, Oct 19th 2011 ] - Market Wire

Presentati al 5o congresso triennale congiunto di .. ivi alla?uso precoce e ai vantaggi a lungo termin

Tue, October 18, 2011

[ Tue, Oct 18th 2011 ] - Market Wire

Greatbatch, Inc. to Host Third Quarter 2011 Earnings Conference Call on October 27, 2011

[ Tue, Oct 18th 2011 ] - Market Wire

Brower Piven Encourages Investors Who Have Losses .. vestment in Stereotaxis, Inc. to Inquire About th

[ Tue, Oct 18th 2011 ] - Market Wire

Exactech Schedules Third Quarter 2011 Earnings Release and Conference Call

[ Tue, Oct 18th 2011 ] - Market Wire

Allon Therapeutics Completes Equity Offering

[ Tue, Oct 18th 2011 ] - Market Wire

Flamel Technologies Announces Multi-Year Supply A .. ith GlaxoSmithKline for Coreg CRa" Microparticles

[ Tue, Oct 18th 2011 ] - Market Wire

MethylGene Receives FDA IND Approval to Begin a P .. ith MGCD290, a Novel Antifungal Product Candidate

[ Tue, Oct 18th 2011 ] - Market Wire

Human Genome Sciences to Sponsor Conference Call to Discuss Third Quarter 2011 Financial Results

[ Tue, Oct 18th 2011 ] - Market Wire

ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2011 Financial Results

[ Tue, Oct 18th 2011 ] - Market Wire

Given Imaging Announces New Study Shows Impact of .. lCam(R) SB on Management of Symptomatic IBD Cases

[ Tue, Oct 18th 2011 ] - Market Wire

Dr. Roberto Romero, NIH Principal Investigator of .. by Columbia Laboratories, Honored with John Ding

[ Tue, Oct 18th 2011 ] - Market Wire

Reflect Scientific, Inc. Introduces Cryometrix Model B-120 Blast Freezer

[ Tue, Oct 18th 2011 ] - Market Wire

Greystone Logistics Announces Preliminary Financial Results for 1st Quarter

[ Tue, Oct 18th 2011 ] - Market Wire

DaVita Announces Estimate of Third Quarter 2011 Results

Mon, October 17, 2011

[ Mon, Oct 17th 2011 ] - Market Wire

Medtronic Elects Michael O. Leavitt to the Board of Directors

[ Mon, Oct 17th 2011 ] - Market Wire

Tripp Levy PLLC Announces Investigation of Anadys Pharmaceuticals

[ Mon, Oct 17th 2011 ] - Market Wire

Futuremed Announces Timing of Third Quarter 2011 Results &;; Conference Call

[ Mon, Oct 17th 2011 ] - Market Wire

Leisureworld Announces October Dividend

[ Mon, Oct 17th 2011 ] - Market Wire

Medtronic Announces 510(k) Clearance for the Aqua .. ined Hemostatic Sealing and Cutting Functionality

[ Mon, Oct 17th 2011 ] - Market Wire

PharmStar Outstanding Common Stock Reduced by 50%

[ Mon, Oct 17th 2011 ] - Market Wire

AdCare Health Systems to Acquire Five Skilled Nursing Facilities in Oklahoma

[ Mon, Oct 17th 2011 ] - Market Wire

Lpath Initiates Dosing of iSONEP in Second of Two Proof-of-Concept Trials

[ Mon, Oct 17th 2011 ] - Market Wire

Marina Biotech, Inc. Announces a $15 Million Purc .. ase Agreement With Lincoln Park Capital Fund, LLC

[ Mon, Oct 17th 2011 ] - Market Wire

Immunovaccine Appoints Wayne Pisano to its Board

[ Mon, Oct 17th 2011 ] - Market Wire

Cellceutix Confident as Cancer Compound Shows Activity in All Cancers Tested

[ Mon, Oct 17th 2011 ] - Market Wire

CytoSorbents Corporation Launches HemoDefend Puri .. for Blood Transfusion Applications at the AABB Co

[ Mon, Oct 17th 2011 ] - Market Wire

Acura Pharmaceuticals Provides Update on Opioid Product Licensed to Pfizer

Sun, October 16, 2011

[ Sun, Oct 16th 2011 ] - Market Wire

China Medical Technologies Announces the Approval .. Technology Enterprise Status for a Major Subsidia

Sat, October 15, 2011

[ Sat, Oct 15th 2011 ] - Market Wire

The Medicines Company's MDCO-2010 Meets Clinical .. ectives in Patients Undergoing Open-Heart Surgery

Fri, October 14, 2011

[ Fri, Oct 14th 2011 ] - Market Wire

Par Pharmaceutical Files Declaratory Judgment to .. s to Disseminate Truthful Information Regarding M

[ Fri, Oct 14th 2011 ] - Market Wire

MannKind to Present at The 18th Annual Newsmakers in the BioTech Industry Conference

[ Fri, Oct 14th 2011 ] - Market Wire

Amarillo Biosciences Issues Corporate Update

[ Fri, Oct 14th 2011 ] - Market Wire

Enzo Reports Record Revenues of $102 Million for Fiscal Year 2011

[ Fri, Oct 14th 2011 ] - Market Wire

Greatbatch, Inc. Elects Anthony P. Bihl III to its Board of Directors

[ Fri, Oct 14th 2011 ] - Market Wire

New Data on Tevaa?s Copaxone® and Laquinimod to Be Highlighted at ECTRIMS/ACTRIMS

[ Fri, Oct 14th 2011 ] - Market Wire

Dynavax to Present at Newsmakers in the Biotech Industry Conference

[ Fri, Oct 14th 2011 ] - Market Wire

MSA Completes Sale of North Carolina Ballistic Vest Business

[ Fri, Oct 14th 2011 ] - Market Wire

Faruqi & Faruqi, LLP Announces Investigation of Stereotaxis, Inc.

[ Fri, Oct 14th 2011 ] - Market Wire

Teva Completes Acquisition of Cephalon

[ Fri, Oct 14th 2011 ] - Market Wire

Skanska Awarded R&D Lab Renovation Contract for USD 80 M, About SEK 512 M

[ Fri, Oct 14th 2011 ] - Market Wire

Columbia Laboratories to Present October 21st at NewsMakers in the Biotech Industry Conference

[ Fri, Oct 14th 2011 ] - Market Wire

Astex Pharmaceuticals to Present at NewsMakers in the Biotech Industry on October 21st

Thu, October 13, 2011

[ Thu, Oct 13th 2011 ] - Market Wire

Kindred Healthcare Commences Registered Exchange Offer for Its 8.25% Senior Notes Due 2019

[ Thu, Oct 13th 2011 ] - Market Wire

Trimel Appoints John Friedrichsen to Its Board of Director

[ Thu, Oct 13th 2011 ] - Market Wire

Amica Mature Lifestyles to Announce First Quarter .. esults and Host Conference Call November 14, 2011

[ Thu, Oct 13th 2011 ] - Market Wire

Strong Pipelines From Allos Therapeutics and Dynavax Tech Poised to Pay Off

[ Thu, Oct 13th 2011 ] - Market Wire

Vanguard Health Systems Appoints Former Tennessee Governor to Board of Directors

[ Thu, Oct 13th 2011 ] - Market Wire

Synageva BioPharma and Trimeris Announce Special Meetings of Stockholders to Approve Merger

[ Thu, Oct 13th 2011 ] - Market Wire

Mercka?s ISENTRESS® (raltegravir) in Combination .. cal and Immunological Efficacy Versus the Efavire

[ Thu, Oct 13th 2011 ] - Market Wire

Micromet Obtains FDA Feedback on Registration Strategy for Blinatumomab in Relapsed/Refractory ALL

[ Thu, Oct 13th 2011 ] - Market Wire

Horizon Pharma Receives U.S. Patent Allowance for DUEXIS(R) in the United States

[ Thu, Oct 13th 2011 ] - Market Wire

U.S. Sales of EGRIFTA(R) Driving Revenue Growth

[ Thu, Oct 13th 2011 ] - Market Wire

Los datos presentados durante el 5 Congreso trien .. or ECTRIMS y ACTRIMS demuestran el compromiso y l

[ Thu, Oct 13th 2011 ] - Market Wire

ISTA Pharmaceuticals Reports Results From the Sec .. URA(TM) Phase 3 Clinical Program for Dry Eye Dise

[ Thu, Oct 13th 2011 ] - Market Wire

China Medical Technologies Receives SFDA Approval .. ed KRAS Assay for Colorectal Cancer Targeted Drug

Wed, October 12, 2011

[ Wed, Oct 12th 2011 ] - Market Wire

Financial Statement 10/11

[ Wed, Oct 12th 2011 ] - Market Wire

Mylan Announces Intention to Refinance Existing Secured Credit Facility

[ Wed, Oct 12th 2011 ] - Market Wire

Dynavax to Host Analyst &;; Investor Day Webcast October 27, 2011

[ Wed, Oct 12th 2011 ] - Market Wire

Media Advisory/REMINDER: Theratechnologies to Announce Financial Results for Third Quarter of 2011

[ Wed, Oct 12th 2011 ] - Market Wire

Analyst View, Impact of Global Events - Research .. n Pharmaceuticals, Inc. and Trustmark Corporation

[ Wed, Oct 12th 2011 ] - Market Wire

Implant Sciences Receives Orders for the QS-B220 .. ench-Top Explosives and Narcotics Trace Detectors

[ Wed, Oct 12th 2011 ] - Market Wire

Ceapro Announces Signing of a Sales Agreement Wit .. s Inc. for its certified All-Natural Active Ingre

[ Wed, Oct 12th 2011 ] - Market Wire

OPKO Completes Sale of Ophthalmic Instrumentation Business

[ Wed, Oct 12th 2011 ] - Market Wire

Data Presented at the 5th Joint Triennial Congres .. nstrates Biogen Ideca?s Novel Science and Commitm

[ Wed, Oct 12th 2011 ] - Market Wire

Study Supports Use of Cambridge Hearta?s MTWA Test as Predictor of Sudden Cardiac Death

[ Wed, Oct 12th 2011 ] - Market Wire

SciClone Pharmaceuticals Announces Preliminary Settlement of Stockholder Derivative Litigation

[ Wed, Oct 12th 2011 ] - Market Wire

Galectin Therapeutics Elects Dr. Marc Rubin to its Board of Directors

[ Wed, Oct 12th 2011 ] - Market Wire

Illumina Announces Novel Human Exome Content Available on Multiple BeadChip Formats

Tue, October 11, 2011

[ Tue, Oct 11th 2011 ] - Market Wire

Luminex Corporation Third Quarter Earnings Release Scheduled for November 1, 2011

[ Tue, Oct 11th 2011 ] - Market Wire

Molina Healthcare of Missouri Receives aCommendablea? NCQA Status

[ Tue, Oct 11th 2011 ] - Market Wire

St. Jude Medical verbessert sein Patientenfernber .. gssystem durch mobile Benachrichtigungsfunktionen

[ Tue, Oct 11th 2011 ] - Market Wire

Healthnostics Launching MicroFill-2160 1st Quarter 2012

[ Tue, Oct 11th 2011 ] - Market Wire

INCIVEKa" (t©lapr©vir) disponible au Canada pour le traitement de l'h©patite C

[ Tue, Oct 11th 2011 ] - Market Wire

GlycoMimetics and Pfizer Enter into Licensing Agr .. rently in Development to Treat Patients Experienc

[ Tue, Oct 11th 2011 ] - Market Wire

Glamsmile Opens Rome Studio, With the Wenzhou Studio Opening to Follow Shortly Thereafter

[ Tue, Oct 11th 2011 ] - Market Wire

Cyanotech Announces 33% Expansion of Astaxanthin Production Capacity

[ Tue, Oct 11th 2011 ] - Market Wire

International Stem Cell's Research Scientists Suc .. t Series of Preclinical Animal Trials of Neuronal

[ Tue, Oct 11th 2011 ] - Market Wire

BioSante Pharmaceuticals Reports Positive LibiGel® Safety Data Review in Phase III Program

[ Tue, Oct 11th 2011 ] - Market Wire

Breakthrough in Multiple Sclerosis Achieved by FO .. IGHT MRI Announced at UC San Diego Medical Center

[ Tue, Oct 11th 2011 ] - Market Wire

Aetna??Michael Elliott???????

[ Tue, Oct 11th 2011 ] - Market Wire

Illumina Introduces Revolutionary Workflow Enhancements for MiSeqa"

Mon, October 10, 2011

[ Mon, Oct 10th 2011 ] - Market Wire

Electromed, Inc. Introduces aSeriously Pinka to Its SmartVest® Product Line

[ Mon, Oct 10th 2011 ] - Market Wire

Dynavax Reports Positive Immunogenicity Data From .. ponsive Populations in HEPLISAV(TM) Phase 3 Trial

[ Mon, Oct 10th 2011 ] - Market Wire

Magellan Health Services Announces New Pharmacy Organization

[ Mon, Oct 10th 2011 ] - Market Wire

Health Net Receives Full URAC Accreditation for Disease Management

[ Mon, Oct 10th 2011 ] - Market Wire

Innovative Pipelines From Avanir and Cyclacel Pharmaceuticals Gain Momentum

[ Mon, Oct 10th 2011 ] - Market Wire

Equity Research on Humana Inc. and WellPoint Inc. - Obamacare Helping Several Health Insurers

[ Mon, Oct 10th 2011 ] - Market Wire

St. Jude Medical Advances Its Remote Patient Monitoring System with Mobile Notifications

[ Mon, Oct 10th 2011 ] - Market Wire

Ligand Enters Into Global Licensing Agreement With Chiva Pharmaceuticals for Fablyn®

[ Mon, Oct 10th 2011 ] - Market Wire

Natus Medical Announces Preliminary 2011 Third Quarter Revenue Results

[ Mon, Oct 10th 2011 ] - Market Wire

Medtronic Announces Results from TTOP-AF Trial De .. of Its Phased RF Ablation System in Treating Per

[ Mon, Oct 10th 2011 ] - Market Wire

United Therapeutics Subsidiary Enters Into Contra .. f Health for Award of up to $45 Million to Suppor

[ Mon, Oct 10th 2011 ] - Market Wire

PAREXEL and National University of Singapore Esta .. Meet Increasing Demand in Asia for Clinical Rese

[ Mon, Oct 10th 2011 ] - Market Wire

Inovio Pharmaceuticals and VGX International to A .. C and Hepatitis B Synthetic Vaccines into Clinica

Sun, October 9, 2011

[ Sun, Oct 09th 2011 ] - Market Wire

Watson Provides Update on District Court Order Concerning Generic Version of LOVENOX®

[ Sun, Oct 09th 2011 ] - Market Wire

Mylan Comments on Death of Company Co-Founder and Former Chairman and CEO Milan "Mike" Puskar

Sat, October 8, 2011

[ Sat, Oct 08th 2011 ] - Market Wire

FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. ;;;;;;; a Once-Daily Therap

[ Sat, Oct 08th 2011 ] - Market Wire

FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. Daily Therapy for Patients with Type 2 Diabetes W

[ Sat, Oct 08th 2011 ] - Market Wire

FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. 9;; a Once-Daily Therapy for Patients with

[ Sat, Oct 08th 2011 ] - Market Wire

FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. ;;; a Once-Daily Therapy for Patients w

[ Sat, Oct 08th 2011 ] - Market Wire

FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. e-Daily Therapy for Patients with Type 2 Diabetes

[ Sat, Oct 08th 2011 ] - Market Wire

KCI Announces Proposed Offering of Senior Notes

[ Sat, Oct 08th 2011 ] - Market Wire

Watson Confirms District Court Order Concerning Generic Version of LOVENOX(R)

[ Sat, Oct 08th 2011 ] - Market Wire

West Increases Quarterly Dividend to $0.18

[ Sat, Oct 08th 2011 ] - Market Wire

Amerigroup Enhances Maternal Outreach Efforts

[ Sat, Oct 08th 2011 ] - Market Wire

IBM Launches University Competition to Combat Growth of Non-Communicable Diseases

Fri, October 7, 2011

[ Fri, Oct 07th 2011 ] - Market Wire

Celgene publica nueva informacin adicional sobre la conclusin del Artculo 20 para REVLIMID®

[ Fri, Oct 07th 2011 ] - Market Wire

NuVasive Completes Acquisition of Impulse Monitor .. and Conference Call of Third Quarter 2011 Results

[ Fri, Oct 07th 2011 ] - Market Wire

Law Offices of Howard G. Smith LLP Continues Inve .. ation of Pharmaceutical Product Development, Inc.

[ Fri, Oct 07th 2011 ] - Market Wire

Advitech and Natunola Announce Completion of Merg .. Private Placement and Change of Name to Botaneco

[ Fri, Oct 07th 2011 ] - Market Wire

Akorn, Inc. Announces Third Quarter 2011 Earnings Release and Conference Call Information

[ Fri, Oct 07th 2011 ] - Market Wire

MEDNAX 2011 Third Quarter Conference Call/Webcast Scheduled for Tuesday, November 1, 2011

[ Fri, Oct 07th 2011 ] - Market Wire

Vertex Announces the Date of its Third Quarter 2011 Financial Results Conference Call and Webcast

[ Fri, Oct 07th 2011 ] - Market Wire

Cardiovascular Systems Announces Preliminary First-Quarter Financial Results

[ Fri, Oct 07th 2011 ] - Market Wire

Analyst View, Impact of Global Events - Research .. n MELA Sciences, Inc. and SIGA Technologies, Inc.

[ Fri, Oct 07th 2011 ] - Market Wire

Expert's Economic Outlook, Global - Equity Resear .. harmaceutical Companies, Inc. and Targacept, Inc.

[ Fri, Oct 07th 2011 ] - Market Wire

Expert's Economic Outlook, Global - Equity Resear .. on Impax Laboratories Inc and Enzo Biochem, Inc.

[ Fri, Oct 07th 2011 ] - Market Wire

Adherex Reports Meeting With FDA's Pediatric Subc .. gs Advisory Committee on the Development of Sodiu

[ Fri, Oct 07th 2011 ] - Market Wire

Senetek Announces Work Plans at Iron Creek Project

Thu, October 6, 2011

[ Thu, Oct 06th 2011 ] - Market Wire

Hansen Medical Announces Settlement of SEC Investigation

[ Thu, Oct 06th 2011 ] - Market Wire

MethylGene Appoints Joseph Walewicz as Vice President, Business and Corporate Development

[ Thu, Oct 06th 2011 ] - Market Wire

DiaMedica Named 2011 Emerging Company of the Year by Life Science Association of Manitoba

[ Thu, Oct 06th 2011 ] - Market Wire

Patient Home Monitoring Announces Unaudited Reven .. for September 2011, and Growth Figures for Q4 20

[ Thu, Oct 06th 2011 ] - Market Wire

Theratechnologies Identifies Second Generation GRF Peptide and Initiates Pre-Clinical Studies

[ Thu, Oct 06th 2011 ] - Market Wire

Equity Research on Gilead Sciences Inc. and Human .. . - Regulatory Approval Key for Biotech Companies

[ Thu, Oct 06th 2011 ] - Market Wire

Peregrine Completes Patient Enrollment in Second- .. er Trial;; Data to Be Unblinded in First H

[ Thu, Oct 06th 2011 ] - Market Wire

Trimel Provides Update on Female Sexual Dysfunction "Anorgasmia" Clinical Program

[ Thu, Oct 06th 2011 ] - Market Wire

Novadaq Reports 165 System Shipments During Third Quarter 2011

[ Thu, Oct 06th 2011 ] - Market Wire

Threshold Pharmaceuticals to Present at the BioCentury NewsMakers Conference

[ Thu, Oct 06th 2011 ] - Market Wire

Alexza and Grupo Ferrer Establish Partnership for .. uvea" (Staccato® Loxapine) in Europe and Latin A

[ Thu, Oct 06th 2011 ] - Market Wire

Greystone Logistics Announces Record Sales in 4th Quarter

[ Thu, Oct 06th 2011 ] - Market Wire

The Ensign Group Acquires La Jolla Skilled Nursing Facility

Wed, October 5, 2011

[ Wed, Oct 05th 2011 ] - Market Wire

Basilea receives request for extraordinary shareh .. lect additional members to the board of directors

[ Wed, Oct 05th 2011 ] - Market Wire

Waters Empowers Advantar Laboratories for Sustained Growth

[ Wed, Oct 05th 2011 ] - Market Wire

Investigational Oral Multiple Sclerosis Therapy T .. ignificantly Reduced Relapse Rate, Disability Pro

[ Wed, Oct 05th 2011 ] - Market Wire

MURRAY FRANK LLP Announces Investigation of Pharmaceutical Product Development, Inc.

[ Wed, Oct 05th 2011 ] - Market Wire

Law Office of Brodsky & Smith, LLC Announces Investigation of DaVita, Inc.

[ Wed, Oct 05th 2011 ] - Market Wire

Voclosporin study published in the American Journal of Transplantation

[ Wed, Oct 05th 2011 ] - Market Wire

OncoSec Releases Devices for Use in Clinical Trials

[ Wed, Oct 05th 2011 ] - Market Wire

Inovio Pharmaceuticals' Synthetic Vaccine for Can .. ost Promising Research at Global Vaccine Congress

Tue, October 4, 2011

[ Tue, Oct 04th 2011 ] - Market Wire

Law Offices of Howard G. Smith LLP Announces Inve .. ation of Pharmaceutical Product Development, Inc.

[ Tue, Oct 04th 2011 ] - Market Wire

Bronstein, Gewirtz & Grossman, LLC Investigates DaVita, Inc.

[ Tue, Oct 04th 2011 ] - Market Wire

POZEN Provides Patent Litigation and Financial Guidance Update

[ Tue, Oct 04th 2011 ] - Market Wire

Faruqi & Faruqi, LLP Announces Investigation of Pharmaceutical Product Development Inc.

[ Tue, Oct 04th 2011 ] - Market Wire

Ryan & Maniskas, LLP Announces Investigation of Pharmaceutical Product Development Inc.

[ Tue, Oct 04th 2011 ] - Market Wire

Neurocrine Biosciences Receives Second Milestone .. $20 Million Under Abbott Collaboration Agreement

[ Tue, Oct 04th 2011 ] - Market Wire

Investigation of Pharmaceutical Product Developme .. oldfarb Branham Law Firm LLP for Potential Shareh

[ Tue, Oct 04th 2011 ] - Market Wire

BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call

[ Tue, Oct 04th 2011 ] - Market Wire

Initial Data from Bio-Path Holdingsa? Phase I Cli .. entation at American Society of Hematology Annual

Mon, October 3, 2011

[ Mon, Oct 03rd 2011 ] - Market Wire

Law Office of Brodsky & Smith, LLC Announces Inve .. tion of Pharmaceuticals Product Development, Inc.

[ Mon, Oct 03rd 2011 ] - Market Wire

Por segundo ao consecutivo, el Humana Walmart-Pre .. a prima mensual ms baja en los 50 estados y en Wa

[ Mon, Oct 03rd 2011 ] - Market Wire

Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2011 Results

[ Mon, Oct 03rd 2011 ] - Market Wire

Tomball Regional Medical Center Completes Sale to Subsidiary of Community Health Systems, Inc.

[ Mon, Oct 03rd 2011 ] - Market Wire

The Law Firm of Levi & Korsinsky, LLP Announces Investigation of American Medical Alert Corp.

[ Mon, Oct 03rd 2011 ] - Market Wire

The Law Firm of Levi & Korsinsky, LLP Announces I .. ation of Pharmaceutical Product Development, Inc.

[ Mon, Oct 03rd 2011 ] - Market Wire

Finkelstein Thompson LLP Announces Investigation of Pharmaceutical Product Development, Inc.

[ Mon, Oct 03rd 2011 ] - Market Wire

Tripp Levy PLLC Announces Investigation of Pharmaceutical Product Development

[ Mon, Oct 03rd 2011 ] - Market Wire

The Briscoe Law Firm and Powers Taylor, LLP Annou .. ation of Pharmaceutical Product Development, Inc.

[ Mon, Oct 03rd 2011 ] - Market Wire

Rigrodsky & Long, P.A. Announces Investigation of Pharmaceutical Product Development, Inc.

[ Mon, Oct 03rd 2011 ] - Market Wire

Medwell Capital to Adopt IFRS

[ Mon, Oct 03rd 2011 ] - Market Wire

IMRIS Announces Retirement of Chief Operating Officer

[ Mon, Oct 03rd 2011 ] - Market Wire

Allegiance Completes Private Placement Of 229,166 Common At $0.48 Per Share

Sun, October 2, 2011

[ Sun, Oct 02nd 2011 ] - Market Wire

HeartWare Reports Additional Clinical Data From B .. nued Access Patients at the 25th European Associa

Sat, October 1, 2011

[ Sat, Oct 01st 2011 ] - Market Wire

HealthSpring Unveils 2012 Medicare Advantage Plans

Fri, September 30, 2011

[ Fri, Sep 30th 2011 ] - Market Wire

Coventry Health Care Joins Forces with Walgreens, .. Part D Plan Available Across the Continental U.S

[ Fri, Sep 30th 2011 ] - Market Wire

Hologic Celebrates 10 Years of Providing Women wi .. nimally Invasive Solution for Their Heavy Periods

[ Fri, Sep 30th 2011 ] - Market Wire

Sangamo BioSciences to Host Conference Call to Di .. m Phase 2b Trial of SB-509 in Diabetic Neuropathy

[ Fri, Sep 30th 2011 ] - Market Wire

Dehaier Medical Appoints Interim Chief Financial Officer

[ Fri, Sep 30th 2011 ] - Market Wire

ADVENTRX Announces Results of FDA Meeting to Discuss Exelbine NDA

[ Fri, Sep 30th 2011 ] - Market Wire

AxoGen, Inc. Announces Completion of Merger, Name Change and Executive Team Changes

[ Fri, Sep 30th 2011 ] - Market Wire

Alliance HealthCare Services Announces Amendment .. t;; Receives Notice Regarding NYSE Listing

[ Fri, Sep 30th 2011 ] - Market Wire

Glancy Binkow & Goldberg LLP Continues Investigation of American Medical Alert Corp.

[ Fri, Sep 30th 2011 ] - Market Wire

Health Management Associates, Inc. Completes the .. alth Partners from Catholic Health Partners, Inc.

Cerus to Release Third Quarter 2011 Results on November 1, 2011

_{//health-fitness.news-articles.net/content/2011/ .. ird-quarter-2011-results-on-november-1-2011.html}
^{Published in Health and Fitness on Thursday, October 13th 2011 at 5:39 GMT by Market Wire}

CONCORD, Calif.--([ BUSINESS WIRE ])--Cerus Corporation (NASDAQ:CERS) announced today that its third quarter 2011 financial results will be released on Tuesday, November 1, 2011, after the close of the stock market. The company will host a conference call and webcast at 4:15 p.m. ET that afternoon, during which management will discuss the Companya�s financial results and provide a general business overview and outlook.

To access the live webcast, please visit the Investor Relations page of the Cerus web site at [ http://investor.cerus.com ]. Alternatively, you may access the live conference call by dialing 866-235-9006 (U.S.) or 631-291-4549 (international).

A replay will be available on the companya�s web site, or by dialing 855-859-2056 (U.S.) or 404-537-3406 (international) and entering conference ID number 45247978. The replay will be available approximately three hours after the call through November 14, 2011.

ABOUT CERUS

Cerus Corporation is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT system is designed to reduce the risk of transfusion-transmitted diseases by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in donated blood. The nucleic acid targeting mechanism of action enables INTERCEPT treatment to inactivate established transfusion threats, such as hepatitis B and C, HIV, West Nile virus and bacteria, and is designed to inactivate emerging pathogens such as influenza, malaria and dengue. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in Europe, Russia, the Middle East and selected countries in other regions around the world. The INTERCEPT red blood cell system is in clinical development. See [ http://www.cerus.com ] for more information.

INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire